In a recent study [24], we found that anti-Notch2 treatment can reduce both HCC and ICC tumor load induced by AKT and neuroblastoma RAS viral oncogene homolog (NRas) oncoproteins, whereas Notch1 suppression decrease HCC and augments ICC occurrence. The gene discussed is AKT1; the disease is neoplasm.